» Articles » PMID: 22894855

Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate

Abstract

Bioluminescence methodologies have been extraordinarily useful due to their high sensitivity, broad dynamic range, and operational simplicity. These capabilities have been realized largely through incremental adaptations of native enzymes and substrates, originating from luminous organisms of diverse evolutionary lineages. We engineered both an enzyme and substrate in combination to create a novel bioluminescence system capable of more efficient light emission with superior biochemical and physical characteristics. Using a small luciferase subunit (19 kDa) from the deep sea shrimp Oplophorus gracilirostris, we have improved luminescence expression in mammalian cells ~2.5 million-fold by merging optimization of protein structure with development of a novel imidazopyrazinone substrate (furimazine). The new luciferase, NanoLuc, produces glow-type luminescence (signal half-life >2 h) with a specific activity ~150-fold greater than that of either firefly (Photinus pyralis) or Renilla luciferases similarly configured for glow-type assays. In mammalian cells, NanoLuc shows no evidence of post-translational modifications or subcellular partitioning. The enzyme exhibits high physical stability, retaining activity with incubation up to 55 °C or in culture medium for >15 h at 37 °C. As a genetic reporter, NanoLuc may be configured for high sensitivity or for response dynamics by appending a degradation sequence to reduce intracellular accumulation. Appending a signal sequence allows NanoLuc to be exported to the culture medium, where reporter expression can be measured without cell lysis. Fusion onto other proteins allows luminescent assays of their metabolism or localization within cells. Reporter quantitation is achievable even at very low expression levels to facilitate more reliable coupling with endogenous cellular processes.

Citing Articles

A Bioluminescent Probe for HS Detection in Tumor Microenvironment.

Lu K, Wang Y, Wang C, Liu R, Yang K, Zhang X ACS Bio Med Chem Au. 2025; 5(1):175-183.

PMID: 39990954 PMC: 11843338. DOI: 10.1021/acsbiomedchemau.4c00102.


Internal cap-initiated translation for efficient protein production from circular mRNA.

Fukuchi K, Nakashima Y, Abe N, Kimura S, Hashiya F, Shichino Y Nat Biotechnol. 2025; .

PMID: 39972222 DOI: 10.1038/s41587-025-02561-8.


Luciferase complementation for cellular assays beyond protein-protein interactions.

Kawamura G, Ozawa T Anal Sci. 2025; .

PMID: 39966321 DOI: 10.1007/s44211-025-00730-y.


A Fluorescent Probe Enables the Discovery of Improved Antagonists Targeting the Intracellular Allosteric Site of the Chemokine Receptor CCR7.

Wurnig S, Huber M, Weiler C, Baltrukevich H, Merten N, Stotzel I J Med Chem. 2025; 68(4):4308-4333.

PMID: 39937529 PMC: 11873976. DOI: 10.1021/acs.jmedchem.4c02102.


Pharmacodynamics of Akt drugs revealed by a kinase-modulated bioluminescent indicator.

Wu Y, Hao C, Gao C, Hageman M, Lee S, Kirkland T Nat Chem Biol. 2025; .

PMID: 39934397 DOI: 10.1038/s41589-025-01846-y.


References
1.
Auld D, Zhang Y, Southall N, Rai G, Landsman M, MacLure J . A basis for reduced chemical library inhibition of firefly luciferase obtained from directed evolution. J Med Chem. 2009; 52(5):1450-8. PMC: 3430137. DOI: 10.1021/jm8014525. View

2.
Tannous B, Kim D, Fernandez J, Weissleder R, Breakefield X . Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther. 2005; 11(3):435-43. DOI: 10.1016/j.ymthe.2004.10.016. View

3.
Remy I, Michnick S . A highly sensitive protein-protein interaction assay based on Gaussia luciferase. Nat Methods. 2006; 3(12):977-9. DOI: 10.1038/nmeth979. View

4.
Simmons S . Fireflies in the coalmine: luciferase technologies in next-generation toxicity testing. Comb Chem High Throughput Screen. 2011; 14(8):688-702. DOI: 10.2174/138620711796504451. View

5.
Rehemtulla A, Taneja N, Ross B . Bioluminescence detection of cells having stabilized p53 in response to a genotoxic event. Mol Imaging. 2004; 3(1):63-8. DOI: 10.1162/15353500200403175. View